Out of the 6 analysts polled by TipRanks, 4 rate Galena stock a Buy, while 2 rate the stock a Hold. With a return potential of 472%, the stock’s consensus target price stands at $2.68.
This is the consensus target, from same article.
Estimates run the gamut from overly conservative IMO to $3.02, of course they will change on a moment's notice with news.
GALE
Galena Biopharma Inc
Showing companies issuing upcoming earnings reports:
Estimate
Consensus
Report Date
WRB
$0.79
Moderate Sell
25 Jul 2016
TXN
$0.72
Moderate Buy
25 Jul 2016
S
$0.08
Moderate Sell
25 Jul 2016
RYAAY
$1.05
Moderate Buy
25 Jul 2016
ROP
$1.61
Hold
25 Jul 2016
RE
$2.72
Moderate Buy
25 Jul 2016
LVS
$0.56
Hold
25 Jul 2016
KRC
$0.85
Strong Buy
25 Jul 2016
KMB
$1.48
Hold
25 Jul 2016
GILD
$3.02
Moderate Buy
25 Jul 2016
ESRX
$1.57
Hold
25 Jul 2016
DHR
$1.09
Moderate Buy
25 Jul 2016
COL
$1.59
Moderate Buy
25 Jul 2016
CNI
$0.83
Moderate Buy
25 Jul 2016
CE
$1.55
Moderate Buy
25 Jul 2016
CDNS
$0.18
Moderate Buy
25 Jul 2016
BRX
$0.5
Hold
25 Jul 2016
AVB
$2.09
Moderate Buy
25 Jul 2016
ACC
$0.53
Hold
25 Jul 2016
LUX
$0.71
N/A
25 Jul 2016
See All
